HomeTSHA • NASDAQ
add
Taysha Gene Therapies Inc
Previous close
$3.11
Day range
$3.01 - $3.22
Year range
$0.50 - $3.89
Market cap
569.47M USD
Avg Volume
1.80M
P/E ratio
-
Dividend yield
-
Primary exchange
NASDAQ
In the news
Financials
Income Statement
Revenue
Net income
(USD) | Dec 2023info | Y/Y change |
---|---|---|
Revenue | 3.60M | 44.04% |
Operating expense | 19.40M | -3.23% |
Net income | 47.74M | 186.68% |
Net profit margin | 1.32K | 160.18% |
Earnings per share | — | — |
EBITDA | -15.43M | 10.20% |
Effective tax rate | — | — |
Balance Sheet
Total assets
Total liabilities
(USD) | Dec 2023info | Y/Y change |
---|---|---|
Cash and short-term investments | 143.94M | 63.79% |
Total assets | 172.73M | 36.79% |
Total liabilities | 97.79M | -21.97% |
Total equity | 74.94M | — |
Shares outstanding | 187.02M | — |
Price to book | 7.77 | — |
Return on assets | -21.43% | — |
Return on capital | -53.47% | — |
Cash Flow
Net change in cash
(USD) | Dec 2023info | Y/Y change |
---|---|---|
Net income | 47.74M | 186.68% |
Cash from operations | -16.12M | -209.55% |
Cash from investing | -10.00K | 99.58% |
Cash from financing | -4.25M | -110.30% |
Net change in cash | -20.38M | -138.03% |
Free cash flow | -149.34M | -900.17% |
About
Founded
2019
Headquarters
Website
Employees
52